Sofinnova Investments’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-651,299
Closed -$85.9M 87
2024
Q1
$85.9M Sell
651,299
-206,672
-24% -$25.5M 4.79% 5
2023
Q4
$93.5M Buy
857,971
+129,567
+18% +$13.4M 5.23% 5
2023
Q3
$75M Buy
728,404
+201,031
+38% +$21.7M 4.73% 4
2023
Q2
$60.9M Sell
527,373
-314,149
-37% -$35.7M 3.99% 7
2023
Q1
$89.5M Buy
841,522
+238,166
+39% +$25.7M 5.73% 3
2022
Q4
$66.9M Buy
603,356
+19,888
+3% +$2.03M 3.97% 7
2022
Q3
$50.2M Buy
583,468
+222,507
+62% +$19.9M 2.92% 7
2022
Q2
$32.9M Buy
+360,961
New +$32M 2.74% 9
2020
Q4
Sell
-199,706
Closed -$15.8M 73
2020
Q3
$15.8M Sell
199,706
-273,129
-58% -$21.4M 1.17% 20
2020
Q2
$34.9M Sell
472,835
-13,222
-3% -$995K 2.2% 10
2020
Q1
$35.7M Buy
486,057
+233,692
+93% +$18.4M 3.3% 7
2019
Q4
$21.9M Buy
+252,365
New +$20.7M 1.58% 14

Other funds holding MRK

Sofinnova Investments's MRK Position: Q2 2024 in Review

Sofinnova Investments sold out of Merck (MRK) in Q2 2024, closing a stake of 651,299 shares — an estimated $85.9M sold.

Sofinnova Investments first reported a position in MRK in Q4 2019 and held it in 12 quarters. The position peaked at $93.5M in Q4 2023. 3,544 funds tracked by Wall St. Rank hold MRK as of Q2 2024.

  • Sofinnova Investments reported no remaining Merck position as of Q2 2024 after selling out during the quarter.
  • Sofinnova Investments sold 651,299 Merck shares in Q2 2024, an estimated $85.9M.
  • Sofinnova Investments first reported a position in Merck in Q4 2019 and held it in 12 quarters.
  • Sofinnova Investments's Merck position peaked at $93.5M in Q4 2023.
  • 3,544 funds tracked by Wall St. Rank held Merck as of Q2 2024.

Based on Sofinnova Investments's 13F filing for Q2 2024, filed 9 Aug 2024.